FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

MEDICARE DRUG BENEFIT Volume 353:2733-2735 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This year, Medicare introduced the prescription-drug benefit — the most significant change in Medicare coverage since the program's inception. As part of a broader strategy for ensuring that Medicare keeps pace with patients' needs, the addition of the drug benefit will help patients and doctors work together to alleviate symptoms and reduce the rate of complications of serious illness. We also expect the benefit to reduce the risk of related, catastrophic financial losses. The challenge is to ensure that these goals are achieved not only in 2006, but also for the foreseeable future.

As the Centers for Medicare and Medicaid . . . [Full Text of this Article]

Source Information

Dr. Bach is a senior adviser and Dr. McClellan the administrator of the Centers for Medicare and Medicaid Services, Washington, D.C.

Related Letters:

Medicare Drug Benefit
Cooper H. A., Lear A. A., Kravitz R. L., Chang S.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1960-1961, May 4, 2006. Correspondence

This article has been cited by other articles:

• Jones, K., Siegel, C., Bertollo, D. N., Samuels, J. (2009). Impact of the Medicare Modernization Act on Dually Eligible Persons With Psychiatric Diagnoses: A New York State Case Study. Psychiatr. Serv. 60: 512-519 [Abstract] [Full Text]  
• Bach, P. B. (2009). Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs. NEJM 360: 626-633 [Full Text]  
• Stubbings, J., Durley, S. F., Lin, S.-J., Kliethermes, M., Aruru, M. D., Evangelista, C., Byun, M. (2007). Implementing the Medicare drug benefit in a diverse inner-city community. Am J Health Syst Pharm 64: 193-199 [Abstract] [Full Text]  
• Robinson, J. C. (2006). The Commercial Health Insurance Industry In An Era Of Eroding Employer Coverage. Health Aff (Millwood) 25: 1475-1486 [Abstract] [Full Text]  
• Soumerai, S. B., Pierre-Jacques, M., Zhang, F., Ross-Degnan, D., Adams, A. S., Gurwitz, J., Adler, G., Safran, D. G. (2006). Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.. Arch Intern Med 166: 1829-1835 [Abstract] [Full Text]  
• Bach, P. B., McClellan, M. B. (2006). The first months of the prescription-drug benefit--a CMS update.. NEJM 354: 2312-2314 [Full Text]  
• Cooper, H. A., Lear, A. A., Kravitz, R. L., Chang, S. (2006). Medicare drug benefit.. NEJM 354: 1960-1961 [Full Text]